Consistent with the results for MCF7 cells, IL-20 expression in another ER(+) breast cancer cell line, T47D, was also enhanced by estrogen treatment and suppressed by the depletion of ER(α) (Supplementary Figure 2A–2C). The gene discussed is ESR1; the disease is breast carcinoma.